eXoZymes, Inc. (EXOZ) vs ImageneBio Inc (IMA)

A side-by-side comparison of eXoZymes, Inc. and ImageneBio Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

EXOZ

eXoZymes, Inc.

$51M

$5.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

IMA

ImageneBio Inc

$52M

$4.60HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — EXOZ vs IMA

growth of $100 · dividends reinvested · last 2y

EXOZ -36.2% (-20.1%/yr)IMA -77.7% (-52.8%/yr)EXOZ compounded faster over this window

EXOZ IMA

EXOZ vs IMA: by the numbers

•IMA is the larger company ($52M vs $51M market cap).
•Both run net losses; EXOZ's is the smaller (0.00% vs -5668.62% net margin).

Metrics side by side

Valuation

Metric	EXOZ	IMA
P/B ratio	14.02	0.37

Profitability

Metric	EXOZ	IMA
Gross margin	0.00%	-29.12%
Operating margin	0.00%	-6056.37%
Net margin	0.00%	-5668.62%
ROE	-278.89%	-36.94%
ROIC	-157.40%	-40.53%

Growth (annualized)

Metric	EXOZ	IMA
Total return CAGR (5Y)	N/A	-50.73%

Go deeper

Full EXOZ analysis Full IMA analysis Interactive comparison tool

Dig into the metrics

eXoZymes ROE ImageneBio ROE eXoZymes operating margin ImageneBio operating margin eXoZymes revenue growth ImageneBio revenue growth eXoZymes free cash flow ImageneBio free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.